Advertisement
Screener

iRhythm Holdings, Inc. (IRTC) Revenue

iRhythm Holdings, Inc. Revenue

iRhythm Holdings, Inc. (IRTC) reported Revenue of $224.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06

  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $224.17M, a 20.08% increase year-over-year.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $199.39M, a 25.66% increase year-over-year.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $208.89M, a 27.12% increase year-over-year.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $192.88M, a 30.74% increase year-over-year.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $747.14M, a 26.24% increase from fiscal 2024.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $591.84M, a 20.13% increase from fiscal 2023.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $492.68M, a 19.90% increase from fiscal 2022.
  • iRhythm Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $410.92M, a 27.29% increase from fiscal 2021.
Period endRevenue from Contract with Customer, Excluding Assessed Tax 3 monthRevenue from Contract with Customer, Excluding Assessed Tax 3 month as first filedRevenue from Contract with Customer, Excluding Assessed Tax 6 monthRevenue from Contract with Customer, Excluding Assessed Tax 6 month as first filedRevenue from Contract with Customer, Excluding Assessed Tax 9 monthRevenue from Contract with Customer, Excluding Assessed Tax 9 month as first filedRevenue from Contract with Customer, Excluding Assessed Tax 12 monthRevenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed
2026-06-30$224.17M
10-Q · filed 2026-08-06
$423.56M
10-Q · filed 2026-08-06
$632.45M
derived: sum of 3 quarters · filed 2026-08-06
$825.34M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$199.39M
10-Q · filed 2026-04-30
$408.28M
derived: sum of 2 quarters · filed 2026-04-30
$601.16M
derived: sum of 3 quarters · filed 2026-04-30
$787.85M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$208.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$401.77M
derived: sum of 2 quarters · filed 2026-02-19
$588.46M
derived: sum of 3 quarters · filed 2026-08-06
$747.14M
10-K · filed 2026-02-19
2025-09-30$192.88M
10-Q · filed 2025-10-30
$379.57M
derived: sum of 2 quarters · filed 2026-08-06
$538.25M
10-Q · filed 2025-10-30
$702.57M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$186.69M
10-Q · filed 2026-08-06
$345.36M
10-Q · filed 2026-08-06
$509.69M
derived: sum of 3 quarters · filed 2026-08-06
$657.23M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$158.68M
10-Q · filed 2026-04-30
$323.00M
derived: sum of 2 quarters · filed 2026-04-30
$470.54M
derived: sum of 3 quarters · filed 2026-04-30
$618.59M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$164.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$311.86M
derived: sum of 2 quarters · filed 2026-02-19
$459.91M
derived: sum of 3 quarters · filed 2026-02-19
$591.84M
10-K · filed 2026-02-19
2024-09-30$147.54M
10-Q · filed 2025-10-30
$295.58M
derived: sum of 2 quarters · filed 2025-10-30
$427.51M
10-Q · filed 2025-10-30
$560.02M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30$148.05M
10-Q · filed 2025-07-31
$279.98M
10-Q · filed 2025-07-31
$412.49M
derived: sum of 3 quarters · filed 2026-02-19
$537.09M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31$131.93M
10-Q · filed 2025-05-01
$264.44M
derived: sum of 2 quarters · filed 2026-02-19
$389.04M
derived: sum of 3 quarters · filed 2026-02-19
$513.17M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$132.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$257.12M
derived: sum of 2 quarters · filed 2026-02-19
$381.25M
derived: sum of 3 quarters · filed 2026-02-19
$492.68M
10-K · filed 2026-02-19
2023-09-30$124.60M
10-Q · filed 2024-10-30
$248.73M
derived: sum of 2 quarters · filed 2024-10-30
$360.17M
10-Q · filed 2024-10-30
$472.79M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$124.13M
10-Q · filed 2024-08-01
$235.57M
10-Q · filed 2024-08-01
$348.18M
derived: sum of 3 quarters · filed 2025-02-20
$452.06M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$111.44M
10-Q · filed 2024-05-02
$224.05M
derived: sum of 2 quarters · filed 2025-02-20
$327.93M
derived: sum of 3 quarters · filed 2025-02-20
$429.98M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$112.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$216.49M
derived: sum of 2 quarters · filed 2025-02-20
$318.54M
derived: sum of 3 quarters · filed 2025-02-20
$410.92M
10-K · filed 2025-02-20
2022-09-30$103.88M
10-Q · filed 2023-11-02
$205.93M
derived: sum of 2 quarters · filed 2023-11-02
$298.30M
10-Q · filed 2023-11-02
$380.11M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$102.05M
10-Q · filed 2023-08-04
$194.43M
10-Q · filed 2023-08-04
$276.23M
derived: sum of 3 quarters · filed 2024-02-22
$361.67M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$92.38M
10-Q · filed 2023-05-04
$174.18M
derived: sum of 2 quarters · filed 2024-02-22
$259.61M
derived: sum of 3 quarters · filed 2024-02-22
$340.89M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$81.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$167.24M
derived: sum of 2 quarters · filed 2024-02-22
$248.51M
derived: sum of 3 quarters · filed 2024-02-22
$322.82M
10-K · filed 2024-02-22
2021-09-30$85.43M
10-Q · filed 2022-11-04
$166.71M
derived: sum of 2 quarters · filed 2022-11-04
$241.02M
10-Q · filed 2022-11-04
$319.83M
derived: sum of 4 quarters · filed 2022-11-04
2021-06-30$81.28M
10-Q · filed 2022-08-05
$155.59M
10-Q · filed 2022-08-05
$234.40M
derived: sum of 3 quarters · filed 2022-08-05
$306.34M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$74.31M
10-Q · filed 2022-05-06
$153.12M
derived: sum of 2 quarters · filed 2022-05-06
$225.06M
derived: sum of 3 quarters · filed 2022-05-06
$275.94M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$78.81M
10-K · filed 2021-02-26
$150.75M
derived: sum of 2 quarters · filed 2021-11-05
$201.63M
derived: sum of 3 quarters · filed 2021-11-05
$265.17M
10-K · filed 2023-02-23
2020-09-30$71.94M
10-Q · filed 2021-11-05
$122.82M
derived: sum of 2 quarters · filed 2021-11-05
$186.36M
10-Q · filed 2021-11-05
$245.46M
derived: sum of 4 quarters · filed 2021-11-05
2020-06-30$50.88M
10-Q · filed 2021-08-09
$114.41M
10-Q · filed 2021-08-09
$173.52M
derived: sum of 3 quarters · filed 2021-08-09
$228.19M
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31$63.53M
10-Q · filed 2021-05-10
$122.64M
derived: sum of 2 quarters · filed 2021-05-10
$177.31M
derived: sum of 3 quarters · filed 2021-05-10
$229.75M
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31$59.10M
10-K · filed 2021-02-26
$113.78M
derived: sum of 2 quarters · filed 2021-02-26
$166.22M
derived: sum of 3 quarters · filed 2021-02-26
$214.55M
10-K · filed 2022-02-28
2019-09-30$54.67M
10-K · filed 2021-02-26
$107.11M
derived: sum of 2 quarters · filed 2021-02-26
$155.45M
10-Q · filed 2020-11-06
$197.23M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$52.44M
10-K · filed 2021-02-26
$53.33M
10-Q · filed 2019-08-06
$100.78M
10-Q · filed 2020-08-07
$100.55M
10-Q · filed 2019-08-06
$142.56M
derived: sum of 3 quarters · filed 2021-02-26
$181.00M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$48.33M
10-K · filed 2021-02-26
$47.21M
10-Q · filed 2019-05-10
$90.12M
derived: sum of 2 quarters · filed 2021-02-26
$128.56M
derived: sum of 3 quarters · filed 2021-02-26
$163.85M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$41.78M
10-K · filed 2020-03-02
$43.16M
10-K · filed 2019-03-04
$80.22M
derived: sum of 2 quarters · filed 2020-03-02
$115.52M
derived: sum of 3 quarters · filed 2020-03-02
$147.28M
10-K · filed 2021-02-26
$147.29M
10-K · filed 2019-03-04
2018-09-30$38.44M
10-K · filed 2020-03-02
$38.10M
10-Q · filed 2018-10-30
$73.73M
derived: sum of 2 quarters · filed 2020-03-02
$105.50M
10-Q · filed 2019-12-23
$104.14M
10-Q · filed 2018-10-30
$133.68M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$35.29M
10-K · filed 2020-03-02
$35.47M
10-Q · filed 2018-08-03
$67.05M
10-Q · filed 2019-12-23
$66.03M
10-Q · filed 2018-08-03
$95.24M
derived: sum of 3 quarters · filed 2020-03-02
$120.27M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$31.76M
10-K · filed 2020-03-02
$30.57M
10-K · filed 2019-03-04
$59.95M
derived: sum of 2 quarters · filed 2020-03-02
$84.98M
derived: sum of 3 quarters · filed 2020-03-02
$108.83M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$28.18M
10-K · filed 2019-03-04
$53.22M
derived: sum of 2 quarters · filed 2019-03-04
$77.07M
derived: sum of 3 quarters · filed 2019-03-04
$99.13M
10-K · filed 2020-03-02
$98.51M
10-K · filed 2019-03-04
2017-09-30$25.04M
10-K · filed 2019-03-04
$48.89M
derived: sum of 2 quarters · filed 2019-03-04
$70.33M
10-Q · filed 2018-10-30
2017-06-30$23.85M
10-K · filed 2019-03-04
$45.29M
10-Q · filed 2018-08-03
2017-03-31$21.44M
10-K · filed 2019-03-04
2016-12-31$64.07M
10-K · filed 2019-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
AtriCure, Inc. (ATRC)United States$3.089B
Heartflow, Inc. (HTFL)United States$4.225B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87